Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin Prophylaxis for Bronchopulmonary Dysplasia (Claprum)
NCT01652118Phase 3Unknown
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital
- Start
- Oct 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in bronchopulmonary dysplasia (BPD) comparing Clarithromycin with Placebo (2 arms). Primary endpoint: Bronchopulmonary dysplasia at 28 days. Status: unknown.
02
Drugs
clarithromycin
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT01652118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01652118.